DETAILED NOTES ON SUVOREXANT

apalutamide will reduce the extent or impact of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of apalutamide, a solid CYP3A4 inducer, with medication that are CYP3A4 substrates can lead to decrease publicity to those medications.Notify individuals that in some instances, patients